Identification of Selective ATP-Competitive CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function
Mark G. Alexandrow(Moffitt Cancer Center), Damon R. Reed(Moffitt Cancer Center)
Cited by 3
Related Papers
Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors
|Oncotarget|2018|33
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function
|Molecular Cancer Therapeutics|2024|6